Product logins

Find logins to all Clarivate products below.


Juliane Ray

General Manager, Commercial

Juliane Ray is the Global Head of Medtech Strategy at Clarivate. In this role, she connects people with intelligence, expertise and workflow tools to bring commercially successful treatments to patients faster and enable teams to make decisions with speed and confidence, from strategy through research and development and, ultimately, commercial execution.

Juliane has held several global leadership roles in the medical device and technology industries. She began her career in consulting at Deloitte and ZS Associates, where she collaborated with life sciences executives on commercial strategy. She spent more than 10 years leading marketing, strategy and operations teams at Cardiovascular Systems Inc (acquired by Abbott Vascular), American Medical Systems (acquired by Boson Scientific) and Landauer (acquired by Danaher) before joining Veeva as Vice President of Medtech Commercial Strategy in 2021 and joining Clarivate in 2024.

Juliane holds an MBA from the University of Virginia (Darden School of Business) and a BA in economics and international studies from Macalester College. She also serves as Board Chair at the Jungle, a nonprofit theater in her home city of Minneapolis, Minnesota.

Related resources

Navigating the choppy waters of 2027 health exchange enrollment Navigating the choppy waters of 2027 health exchange enrollment
Blog October 30, 2026
Navigating the choppy waters of 2027 health exchange enrollment
Biopharma Biotech HMO Managed care Market Access MCO Patient PBM Pharma Policy Real-World Data Regulatory U.S.
Most Favored Nation drug pricing: How it works Most Favored Nation drug pricing: How it works
Blog October 29, 2026
Most Favored Nation drug pricing: How it works
Biopharma Biotech Commercialization Market Access Pharma Policy pricing Regulatory U.S.
Multi-product portfolios: addressing complexity through smarter value communication Multi-product portfolios: addressing complexity through smarter value communication
Blog October 9, 2026
Multi-product portfolios: addressing complexity through smarter value communication
Biopharma Commercialization HMO HTA Launch Managed care MCO Payer PBM Pharma pricing
Understanding the impact of drug shortages across markets for API manufacturers Understanding the impact of drug shortages across markets for API manufacturers
Blog October 9, 2026
Understanding the impact of drug shortages across markets for API manufacturers
Biopharma Manufacturing Real-World Data Supply chain